United States

Vaping ailments put damper on cannabis rise

Vaping-related illnesses are killing the buzz for entrepreneurs who have been riding high on the marijuana legalization boom. Sales of vaping products — the fastest-growing segment of the burgeoning pot market — are falling nationwide amid reports of hundreds of mysterious lung ailments — the vast majority of which have been linked to vaping THC, the main psychoactive compound in marijuana that gives the high sensation. At Evergreen Organix, the largest producer of edibles, topicals and vapes in Nevada — owned by publicly traded Cannabis One — there’s been a “definite slowdown” in the demand for vaping products, Cannabis One CEO Jeff Mascio told The Post. “I think it’s been a knee-jerk reaction, a little too extre ...